This issue covers a diverse range of topics, including: The mental health crisis in dentistry; molar distalization for Class II malocclusion; slow maxillary expansion for cleft lip and palate patients; planning successful smile makeovers; navigating Malaysia's evolving oral healthcare landscape; and the convergence of emerging technologies revolutionizing dental practice.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

DRA DIGEST: May, 2024 edition

Welcome to DRA DIGEST — the Newsletter of Dental Resource Asia (DRA).

Dear DRA Digest Community,

The recent conviction and 20-year sentence of Dr. Jay M. Sadrinia, a Kentucky dentist who unlawfully prescribed opioids leading to a patient’s fatal overdose, serves as a sobering reminder of the grave implications surrounding the use of these powerful narcotics in dental practice. While opioid analgesics have proven efficacy in managing acute dental pain, their potential for abuse and addiction necessitates a delicate balance between providing relief and ensuring patient safety.

Dental pain, often acute and debilitating, poses significant challenges in its management. For patients unable to take nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen due to contraindications or allergies, opioids have traditionally been the go-to option for severe cases. However, the broader opioid crisis underscores the need to explore alternative nonopioid analgesics to mitigate the risks associated with these highly addictive substances.

A pioneering clinical trial conducted by researchers at the University of Texas offers a glimmer of hope in this regard. The study’s findings suggest that cannabidiol (CBD), a non-psychoactive component of cannabis, can effectively reduce acute dental pain while exhibiting a favorable safety profile. With significant pain reduction and improved bite force observed in the CBD-treated groups, this natural compound emerges as a promising alternative to synthetic opioids.

The potential of CBD as an analgesic warrants further investigation and comprehensive assessments. As more states legalize cannabis for medical and recreational use, the opportunity to explore its therapeutic applications, including dental pain management, becomes increasingly viable. However, it is crucial to navigate this terrain with caution, adhering to evidence-based practices and prioritizing patient safety above all else.

As the healthcare community grapples with the complexities of pain management, striking a delicate balance between providing effective relief and safeguarding against the perils of addiction and abuse becomes an imperative. Ultimately, the well-being of patients must remain the unwavering priority, guiding dentists’ decisions and shaping a future where dental care is not only pain-free but also free from the specter of opioid-related harm.

NEWS

PRODUCTS

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.